As of 2025-12-19, the Relative Valuation of StageZero Life Sciences Ltd (SZLS.TO) is (0.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 CAD, the upside of StageZero Life Sciences Ltd based on Relative Valuation is -132.0%.
The range of the Relative Valuation is (0.01) - (0.01) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.9x - 1.2x | 1.1x |
| Forward P/E multiples | 0.4x - 0.6x | 0.5x |
| Fair Price | (0.01) - (0.01) | (0.01) |
| Upside | -135.2% - -124.8% | -132.0% |
| Date | P/E |